As World Obesity Day spotlights rising obesity rates, GLP-1s reshape treatment and coverage debates, with persistence, affordability and long-term value driving payer decisions. Most days, including World Obesity Day, the conversations around weight management have been much different than they were just a few years ago. Obesity rates remain high, but new data suggests injectable glucagon-like peptide-1 (GLP-1) drugs are beginning to influence both clinical practice and utilization trends across the healthcare system.
FAIR Health has earned the trust of many of the nation’s largest health plans, which rely on us to store, de-identify, aggregate and analyze their claims information. Our security policies, processes and protocols meet the industry’s most exacting standards, as demonstrated by our HITRUST, SOC 2 and CMS QE certifications.
FAIR Health has earned the trust of many of the nation’s largest health plans, which rely on us to store, de-identify, aggregate and analyze their claims information.
Wed, April 17, 2024
Fifteen Years of Advancing Health Literacy and Cost Transparency: A Free Webinar on FAIR Health’s Award-Winning Consumer Resources